• SENSEX 76,738.17
    585.31 (+0.77%)
  • BANKNIFTY 57,380.60
    208.60 (+0.36%)
  • Gland Pharma
    2,826.60 1,575.00(%)
  • Tata Technolog.
    830.10 890.15(%)
  • IFCI
    103.95 101.60(%)
  • HFCL
    231.40 257.00(%)
  • Lumino Inds
    122.00 119.00(%)
  • Jindal Worldwide
    57.06 47.55(%)
  • Netweb Technol.
    5,424.00 5,810.00(%)
  • Angel One
    308.20 360.20(%)
  • HBL Engineering
    723.85 1,121.95(%)
  • Multi Comm. Exc.
    3,257.00 3,479.80(%)
  • Adani Total Gas
    620.85 859.70(%)
  • Lenskart Solut.
    694.75 680.95(%)
  • Oberoi Realty
    1,932.25 1,985.00(%)
  • RBL Bank
    413.50 410.45(%)
  • Tejas Networks
    613.50 644.75(%)
  • Polycab India
    8,308.55 6,660.50(%)
  • Antelopus Selan
    986.05 357.00(%)
  • Nuvoco Vistas
    353.50 477.35(%)
  • One 97
    1,691.50 1,732.00(%)
  • Reliance Industries
    1,332.30 1,611.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Valiant Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017
100.93 5 (4.99%)
  • As on 04 Sep 2026 (EOD)

  • Today’s Low

    99.00

  • Today’s High

    100.93

  • Open

    99.50

  • Perv Close

    96.13

  • 52W Low

    49.51

  • 52W High

    110.70

Key Indicators

  • P/E(TTM)

    42.05

  • Mar.Cap (₹Cr.)

    548.18

  • Div & Yield %

    0.00

  • Book Value(₹)

    58.87

  • Debt-Equity Ratio

    4.99

  • AGM Date

    03-Sep-2026

  • EPS

    2.43

  • P/E Ratio

    42.05

Financials Ratios

  • Debt-Equity Ratio

    0.41

  • Mar.Cap (₹Cr.)

    548.18

  • RONW (%)

    -1.71

  • ROCE (%)

    -1.63

Score Board

  • Equity (₹ in Cr.)

    54.31

  • BV (₹)

    58.90

  • Sales( ₹ in Cr.)

    217.04

  • NP (in Cr.)

    5.55

  • NP Var(%)

    268.0

  • Div%

    0.0

  • CPS (₹)

    1.40

  • EPS (₹)

    1.00

  • Traded Value (₹ in Lakhs)

    554.91

  • 52 Week High

    110.70

  • 52 Week Low

    49.51

  • Price BSE

    102.0

  • Price NSE

    101.00

  • Market Capital( in Cr.)

    554.91

  • P/C Ratio

    70.90

  • P/E Ratio

    99.90

  • Price Vs.BV

    1.00

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 133.36 182.05 333.91 291.52 182.37 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 133.36 182.05 333.91 291.52 182.37 -
Other Income 5.43 9.68 4.86 1.95 1.41 -
Stock Adjustments -3.86 1.14 0.24 1.97 0.13 -
Total Income 134.93 192.87 339.01 295.44 183.91 -
EXPENDITURE :            
Raw Materials 112.19 168.66 276.76 236.19 120.53 -
Power and Fuel Cost 5.94 8.33 7.37 4.38 3.17 -
Employee Cost 4.39 4.31 4.61 3.06 2.71 -
Other Manufacturing Expenses 3.65 6.07 4.86 3.70 3.55 -
Selling and Administration Expenses 2.74 2.76 4.09 2.76 2.25 -
Miscellaneous Expenses 5.27 1.46 1.37 1.09 0.29 -
Employee Benefit Expenses 4.39 4.31 4.61 3.06 2.71 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 134.18 191.59 299.06 251.18 132.50 -
Operating Profit 0.76 1.28 39.95 44.26 51.41 -
Interest 0.18 0.08 0.25 0.07 1.78 -
Gross Profit 0.58 1.20 39.70 44.19 49.63 -
Depreciation 2.02 1.95 1.56 2.49 2.61 -
Profit Before Tax -1.44 -0.75 38.14 41.70 47.02 -
Current Tax 0.06 -0.98 8.80 14.47 16.46 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.65 -0.11 0.34 -0.26 -0.03 -
Reported Net Profit -2.15 0.34 29.00 27.50 30.59 -
Extraordinary Items 1.15 3.20 0.00 0.03 0.00 -
Adjusted Net Profit -3.30 -2.86 29.00 27.47 30.59 -
Adjustment below Net Profit 0.00 0.18 0.03 -48.92 19.37 -
P & L Balance brought forward 52.11 51.59 22.56 78.08 28.12 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 34.10 0.00 -
P & L Balance carried down 49.96 52.11 51.59 22.56 78.08 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr -0.49 0.08 8.91 16.89 29.14 -
Earnings Per Share(Adj)-Unit Curr -0.45 0.07 - - - -
Book Value 53.94 54.52 30.86 43.89 84.36 -
Book Value(Adj)-Unit Curr 50.06 50.60 - - - -

Shareholding Pattern

  • Promoter Group

    74.94%

  • Public Share Holding

    25.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 25,437,500 46.84 25,437,500 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 15,263,987 28.10 15,263,987 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 40,701,487 74.94 40,701,487 8
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 1,703,380 3.14 1,703,380 56
Clearing Members 542,977 1.00 542,977 13
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 115,551 0.21 115,551 98
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 844,836 1.56 844,836 547
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 4,665,618 8.59 4,665,618 63
Individuals holding nominal share capital up to Rs. 1 lakh 5,603,866 10.32 5,603,866 13,545
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 13,611,013 25.06 13,611,013 14,333
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 54,312,500 100.00 54,312,500 14,341

Company Background

Valiant Laboratories LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Valiant Laboratories Ltd
  • BSE Code : 79218.0
  • ISIN : INE0JWS01017

  • Incorporation Year

    2021

  • Registered Office

    104 Udyog Kshetra Mulund
    Goregaon Link Rd Mulund West, Mumbai,
    Maharashtra-400080

  • Telephone

    +91 22 49712001

  • FAX

  • Chairman

    Mulesh Manilal Savla

  • Managing Director

  • Company Secretary

    Akshay Gangurde

  • Auditor

    Raman S Shah & Co

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Valiant Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Valiant Laborato 102.17 138.79 133.36 42.05 -1.05
Abbott India 25,878.50 7,217.19 6,929.05 34.06 43.78
Astrazeneca Phar 6,946.95 2,304.07 2,275.58 102.39 27.86
Glaxosmi. Pharma 2,935.35 3,932.76 3,790.20 46.89 58.17
Novartis India 1,614.95 398.23 356.27 40.78 16.64
Cipla 1,389.00 20,102.60 18,979.95 36.50 13.88
Bliss GVS Pharma 636.90 773.53 729.81 59.14 12.51
Amrutanjan Healt 507.20 520.13 502.55 27.17 24.16
Fermenta Biotec. 502.80 474.15 450.25 23.47 18.77
Guj. Themis Bio. 425.00 152.47 150.80 113.64 27.21
Ambalal Sarabhai 43.88 19.52 3.94 81.26 6.77